AGIOLAX

Brand name authorized in: Brazil Spain Finland France Hong Kong Ireland Netherlands Poland

Active ingredients

The drug AGIOLAX contains one active pharmaceutical ingredient (API):

1 Sennosides
UNII F887D1637W - SENNOSIDE B

The sugar moiety of the sennosides is removed by bacteria in the large intestine releasing the active anthrone fraction. This stimulates peristalsis via the submucosal and myenteric nerve plexuses.

Read about Sennosides

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Senna glycosides, combinations
A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AB Contact laxatives
Discover more medicines within A06AB56
Ispaghula, combinations
A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AC Bulk producers
Discover more medicines within A06AC51

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 541519120017117, 541519120017217
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 56285
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 182529, 395829
FR
Base de données publique des médicaments
Identifier(s): 66768488
HK
Department of Health Drug Office
Identifier(s): 57858
PL
Rejestru Produktów Leczniczych
Identifier(s): 100003283